Fundraising FoxFirst Biotherapeutics
Yongin-si, KR · 4 known investors
Find your way into First Biotherapeutics
Sign up to find every way you can get introduced to First Biotherapeutics
- Your email: who you already know at First Biotherapeutics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the First Biotherapeutics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
1STBIO (퍼스트바이오) is a biotechnology company developing drug programs, including the HPK1 inhibitor immuno-oncology candidate FB849 and the NLY02 program. It focuses on advancing therapeutic pipelines to bring treatments to patients.
Investors · 4
Frequently asked questions
- What does First Biotherapeutics do?
- 1STBIO (퍼스트바이오) is a biotechnology company developing drug programs, including the HPK1 inhibitor immuno-oncology candidate FB849 and the NLY02 program. It focuses on advancing therapeutic pipelines to bring treatments to patients.
- Who are First Biotherapeutics's investors?
- First Biotherapeutics's investors include AF WPartners, Groom Investment, Hyundai Venture Investment Corporation, Solidus Investment.
- Where is First Biotherapeutics headquartered?
- First Biotherapeutics is headquartered in Yongin-si, KR.